Related Experiment Video
Updated: Aug 4, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Follicular conjunctivitis on Dipivefrin therapy for glaucoma
J A Coleiro1, H Sigurdsson, J A Lockyer
1Department of Ophthalmology, Ninewells Hospital and Medical School, Dundee, Scotland.
Abstract:
Dipivefrin (Propine) is an effective ocular hypotensive agent. Follicular conjunctivitis has been observed in an unexpectedly high incidence of glaucoma patients on this topical therapy. Severe discomfort was experienced by a few patients. Follicles resolved after withdrawal of this medication, but may persist or recur upon subsequent treatment with other adrenaline related compounds. Regular examination of the conjunctiva is recommended for early signs of this side-effect, which initially may be symptom free.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Microbiome of the Eye

